Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Genetics in Medicine, Published online: 02 August 2021; doi:10.1038/s41436-021-01287-7Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Source: Genetics in Medicine - August 2, 2021 Category: Genetics & Stem Cells Authors: Ravi Savarirayan Louise Tofts Melita Irving William R. Wilcox Carlos A. Bacino Julie Hoover-Fong Rosendo Ullot Font Paul Harmatz Frank Rutsch Michael B. Bober Lynda E. Polgreen Ignacio Ginebreda Klaus Mohnike Joel Charrow Daniel Hoernschemeyer Keiichi Ozo Source Type: research